A Vancouver-based research team led by Canada’s most cited neuroscientist, Dr. Patrick McGeer, has successfully carried out studies suggesting that, if started early enough, a daily regimen of the non-prescription NSAID (nonsteroidal anti-inflammatory drug) ibuprofen can prevent the onset of Alzheimer’s disease.
This means that by taking an over-the-counter medication, people can ward off a disease that, according to Alzheimer’s Disease International’s World Alzheimer Report 2016, affects an estimated 47 million people worldwide, costs health care systems worldwide more than US$818 billion  per year and is the fifth leading cause of death in those aged 65 or older.
The Alzheimer’s Association estimates that there are more than 5 million cases in the United States alone, with a new case being identified every 66 seconds. The annual cost to the country in 2017 is estimated have been US$259 billion, with that figure predicted to potentially rise to US$1.1 trillion  by 2050.
Dr. McGeer, who is President and CEO of Vancouver-based Aurin Biotech, and his wife, Dr. Edith McGeer, are among the most cited neuroscientists in the world. Their laboratory is world-renowned for their 30 years of work in neuroinflammation and neurodegenerative diseases, particularly Alzheimer’s disease. A paper detailing Dr. McGeer’s most recent discoveries has been published in the prestigious Journal of Alzheimer’s Disease.
In 2016, Dr. McGeer and his team announced that they had developed a simple saliva test that can diagnose Alzheimer’s disease, as well as predict its future onset. The test is based on measuring the concentration of the peptide amyloid-beta protein 42 (Abeta 42) secreted in saliva. In most individuals, the rate of Abeta 42 production is almost exactly the same regardless of sex or age. However, if that rate of production is two to three times higher, those individuals are destined to develop Alzheimer’s disease. That is because Abeta 42 is a relatively insoluble material, and although it is made everywhere in the body, deposits of it occur only in the brain, causing neuroinflammation, which destroys neurons in the brains of people with Alzheimer’s disease.
Contrary to the widely held belief that Abeta 42 is made only in the brain, Dr. McGeer’s team demonstrated that the peptide is made in all organs of the body and is secreted in saliva from the submandibular gland. As a result, with as little as one teaspoon of saliva, it is possible to predict whether an individual is destined to develop Alzheimer’s disease. This gives them an opportunity to begin taking early preventive measures such as consuming non-prescription non-steroidal drugs (NSAIDs) such as ibuprofen.
“What we’ve learned through our research is that people who are at risk of developing Alzheimer’s exhibit the same elevated Abeta 42 levels as people who already have it; moreover, they exhibit those elevated levels throughout their lifetime so, theoretically, they could get tested anytime,” says Dr. McGeer. “Knowing that the prevalence of clinical Alzheimer’s Disease commences at age 65, we recommend that people get tested ten years before, at age 55, when the onset of Alzheimer’s would typically begin. If they exhibit elevated Abeta 42 levels then, that is the time to begin taking daily ibuprofen to ward off the disease.
“Unfortunately, most clinical trials to date have focused on patients whose cognitive deficits are already mild to severe, and when the therapeutic opportunities in this late stage of the disease are minimal. Consequently, every therapeutic trial has failed to arrest the disease’s progression. Our discovery is a game changer. We now have a simple test that can indicate if a person is fated to develop Alzheimer’s disease long before it begins to develop. Individuals can prevent that from happening through a simple solution that requires no prescription or visit to a doctor. This is a true breakthrough since it points in a direction where AD can eventually be eliminated.”
The Latest on: Alzheimer’s disease
via Google News
The Latest on: Alzheimer’s disease
A single concussion may increase risk of Parkinson's disease
on April 18, 2018 at 1:01 pm
At the start of the study, none had Parkinson's disease or dementia. All traumatic brain injuries were diagnosed by a physician. A total of 1,462 of the participants were diagnosed with Parkinson's disease at least one year and up to 12 years after the ... […]
This Man's Genes Have Left Him Battling Early Onset Alzheimer's at 45
on April 18, 2018 at 12:49 pm
... in Oliver's family have been impacted by the form of dementia due to genetics People with familial early onset Alzheimer's disease have a 50 percent chance of passing the genetic mutation onto their children Matt Oliver lost his mother, brother ... […]
Alzheimer’s Disease Starts in Childhood, With Symptoms Found in Babies Less Than a Year Old, Study Shows
on April 18, 2018 at 12:04 pm
A new study found shocking evidence to suggest that Alzheimer's disease begins in childhood, with babies younger than a year old displaying signs of the disease. The research emphasized that earlier intervention is necessary to prevent the disease and ... […]
The Menopause-Alzheimer’s Connection
on April 18, 2018 at 9:19 am
In the next three minutes, three people will develop Alzheimer’s disease. Two of them will be women. There are 5.7 million Alzheimer’s patients in the United States. By 2050, there will probably be as many as 14 million, and twice as many women as men ... […]
Could clocking in enough sleep decrease your Alzheimer’s risk?
on April 18, 2018 at 9:10 am
And according to new research, it also plays a role in lowering your risk of getting Alzheimer’s disease. Basically, sleep is magic. The small study published in the Proceedings of the National Academy of Sciences found that losing just one night of ... […]
Researchers demonstrate the presence of beta-amyloid dimers in the brains of patients with Alzheimer's
on April 18, 2018 at 3:29 am
"Because we can't work with the brains of living subjects, we now need to determine whether these dimers are present in the cerebrospinal fluid of individuals with Alzheimer´s disease and then perform clinical trials to associate their presence with the ... […]
Army vet battles early onset Alzheimer’s aged just 45 – after losing mum and both siblings to disease
on April 18, 2018 at 1:43 am
AN ARMY veteran is battling early onset Alzheimer’s aged just 45 – after losing his mum and both siblings to the disease. Matt Oliver was just 41 when he was diagnosed with the crippling illness after it wiped out three members of his close family. […]
3 Easy Ways You Can Make a Difference in the Fight Against Alzheimer’s Disease
on April 17, 2018 at 5:14 pm
You don’t have to be a scientist, politician, or millionaire to make a big difference in the fight against Alzheimer’s. Talk to the women who are battling stigma, lobbying Congress to get more critical funding for research, and helping to make ... […]
The Atherton woman raising millions for Alzheimer’s research
on April 17, 2018 at 2:14 pm
Photo: James Tensuan / Special To The Chronicle Back in 1993, Alzheimer’s was rarely discussed in public, so it was hard enough for Michaela “Mikey” Hoag and her five siblings to accept that their father, an investment banker, had the disease ... […]
via Bing News